Pharmabiz3h
Novartis to buy Boston-based clinical-stage biopharma company Anthos Therapeutics for up to $3.1 billion
Novartis to buy Boston-based clinical-stage biopharma company Anthos Therapeutics for up to $3.1 billion: Basel Tuesday, February 11, 2025, 17:45 Hrs [IST] Novartis announced that ...
Pharmabiz3h
CARsgen’s first enrolled subject in the THANK-u Plus platform-based allogeneic CAR-T trial achieves sCR at week 4
CARsgen’s first enrolled subject in the THANK-u Plus platform-based allogeneic CAR-T trial achieves sCR at week 4: Shanghai, China Tuesday, February 11, 2025, 18:00 Hrs [IST] CA ...
Pharmabiz4h
Nutrify competes five years of innovation in nutrition now marks its US entry with new office in Somerset, New Jersey
Nutrify competes five years of innovation in nutrition now marks its US entry with new office in Somerset, New Jersey: Our Bureau, Bengaluru Tuesday, February 11, 2025, 16:50 Hrs ...
Pharmabiz4h
Syensqo & Bota Bio partner to develop pioneering biomimetic ingredients for hair and scalp care
Syensqo & Bota Bio partner to develop pioneering biomimetic ingredients for hair and scalp care: Brussels Tuesday, February 11, 2025, 17:00 Hrs [IST] Syensqo, a science company de ...
Pharmabiz5h
Even Healthcare’s works on lowering post-surgery care readmissions by 50%, plans to open new hospitals
Even Healthcare’s works on lowering post-surgery care readmissions by 50%, plans to open new hospitals: Our Bureau, Bengaluru Tuesday, February 11, 2025, 16:15 Hrs [IST] Even He ...
Pharmabiz5h
US FDA grants fast track designation to Nektar Therapeutics’ rezpegaldesleukin to treat moderate-to-severe atopic dermatitis
US FDA grants fast track designation to Nektar Therapeutics’ rezpegaldesleukin to treat moderate-to-severe atopic dermatitis: San Francisco Tuesday, February 11, 2025, 16:00 Hrs ...
Pharmabiz7h
PHC and CCRM collaborate to develop primary T-cell expansion culture processes to enhance efficiency and improve cell quality
PHC and CCRM collaborate to develop primary T-cell expansion culture processes to enhance efficiency and improve cell quality: Tokyo, Japan Tuesday, February 11, 2025, 14:00 Hrs [ ...
Pharmabiz7h
NPPA fixes retail price of 42 formulations, revise prices based on review orders
NPPA fixes retail price of 42 formulations, revise prices based on review orders: Our Bureau, New Delhi Tuesday, February 11, 2025, 13:30 Hrs [IST] The National Pharmaceutical Pri ...
Pharmabiz5h
Asia Pharma Expo to showcase cutting-edge advancements in mfg
Asia Pharma Expo to showcase cutting-edge advancements in mfg: Our Bureau, Mumbai Tuesday, February 11, 2025, 15:40 Hrs [IST] The 16th Asia Pharma Expo 2025 & Asia Lab Expo 2025, ...
Pharmabiz10h
NUS scientists develop realistic ‘micro-gut’ model to study the relationship between gut microbes and human diseases
NUS scientists develop realistic ‘micro-gut’ model to study the relationship between gut microbes and human diseases: Our Bureau, Mumbai Tuesday, February 11, 2025, 11:00 Hrs ...
Pharmabiz8h
CStone Pharma announces inclusion of Cejemly as a first-line combination therapy for NSCLC in ESMO guideline
In combination with fluoropyrimidine- and platinum-containing chemotherapy as first-line treatment for unresectable locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) ...
Pharmabiz11h
Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema
Bayer seeks European approval of extended 6-month treatment interval for Eylea 8 mg to treat nAMD & diabetic macular edema: Berlin Tuesday, February 11, 2025, 10:00 Hrs [IST] Baye ...